Craneware plc - Vesting of LTIP Awards and Total Voting Rights
Craneware plc
("Craneware" or the "Company")
Vesting of Long Term Incentive Plan Awards and Total Voting Rights
|
Director / other PDMR |
Gross number of Shares from conditional share awards vested on |
Number of shares withheld to satisfy tax liabilities on vesting of conditional share awards |
Net number of Shares received from conditional share awards vested on |
Percentage of issued share capital* of the Company |
|
|
|
|
|
|
|
|
24,269 |
(14,028) |
10,241 |
0.029% |
|
|
|
|
|
|
|
|
18,039 |
(10,427) |
7,612 |
0.021% |
|
|
|
|
|
|
|
|
12,400 |
(7,168) |
5,232 |
0.015% |
|
|
|
|
|
|
|
|
10,581 |
(2,826) |
7,755 |
0.022% |
|
|
|
|
|
|
*excluding 33,349 Ordinary Shares held in treasury.
The net amount of Shares received by three of the Directors and the Chief Legal Officer, as shown in the table above, from the vested LTIP awards was after payment of the associated tax liabilities.
No consideration was payable by each of the three Directors or by the other PDMR to receive the Shares from these LTIP awards.
The net number of Shares from these vested LTIP awards received by each of the three Directors and the other PDMR are subject to a two year post-vesting holding period.
Following this transaction,
Total Voting Rights
Following the vesting of these conditional share awards and also the vesting of conditional share awards for certain other employees on
PDMR notification:
1. Details of the Restricted Person / person closely associated with him or her
a) Name Keith Neilson
2. Reason for the notification
a) Position / status CEO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 24,269, Price(s)
2) Volumes(s) surrendered 14,028, Price(s)
e) Aggregated information:
i. Aggregated volume 1) 24,269
2) 14,028
ii. Price(s) 1)
2)
f) Date of the transaction 2025-11-18
g) Place of the transaction Outside a trading venue
PDMR notification: Craig Preston
1. Details of the Restricted Person / person closely associated with him or her
a) Name Craig Preston
2. Reason for the notification
a) Position / status CFO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 18,039, Price(s)
2) Volumes(s) surrendered 10,427, Price(s)
e) Aggregated information:
i. Aggregated volume 1) 18,039
2) 10,427
ii. Price(s) 1)
2)
f) Date of the transaction 2025-11-18
g) Place of the transaction Outside a trading venue
PDMR notification: Isabel Urquhart
1. Details of the Restricted Person / person closely associated with him or her
a) Name Isabel Urquhart
2. Reason for the notification
a) Position / status Chief People Officer
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 12,400, Price(s)
2) Volumes(s) surrendered 7,168, Price(s)
e) Aggregated information:
i. Aggregated volume 1) 12,400
2) 7,168
ii. Price(s) 1)
2)
f) Date of the transaction 2025-11-18
g) Place of the transaction Outside a trading venue
PDMR notification: Eric Carter
1. Details of the Restricted Person / person closely associated with him or her
a) Name Eric Carter
2. Reason for the notification
a) Position / status Chief Legal Officer
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 10,581, Price(s)
2) Volumes(s) surrendered 2,826, Price(s)
e) Aggregated information:
i. Aggregated volume 1) 10,581
2) 2,826
ii. Price(s) 1)
2)
f) Date of the transaction 2025-11-18
g) Place of the transaction Outside a trading venue
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications (Financial PR) +44 (0)20 3405 0205
Caroline Forde, Kinvara Verdon, Sarah Peters craneware@almastrategic.com
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Neil Patel, Benjamin Cryer, Kate Bannatyne
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Virginia Bull, James Smith
Berenberg (Joint Broker) +44 (0)20 3207 7800
Mark Whitmore, Richard Andrews, Patrick Dologhan
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE